|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yen cj"
Showing items 36-85 of 99 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2019-04-12 |
Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer
|
Hsiao, JR;Lee, WT;Ou, CY;Huang, CC;Chang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2019-04 |
Oral hygiene and the overall survival of head and neck cancer patients
|
Chang, CC;Lee, WT;Hsiao, JR;Ou, CY;Huang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2019-01-12 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
|
Yen, CJ;Tsou, HH;Hsieh, CY;Chu, CY;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY;Chang, KY |
| 國家衛生研究院 |
2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, LT;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Yen, CJ;Chen, MH;Tsou, HH |
| 國家衛生研究院 |
2018-10-01 |
The influence of pre-diagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients
|
Lee, WT;Hsiao, JR;Ou, CY;Huang, CC;Chang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 臺大學術典藏 |
2018-09-10T08:06:10Z |
Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults
|
Hwang, JJ;Lin, LY;Hwang, Juey-Jen;Lin, Lian-Yu;Yu, YH;Yu, Yau-Hua;Chang, CC;Chang, Chien-Cheng;Chang, KJ;HON-MAN LIU;Chang, King-Jen;Yen, CJ;Yen, Chung-Jen;LIAN-YU LIN;Liu, HM;CHUNG-JEN YEN;CY;Liu, Hon-Man;Chen, Ching-Yu;JUEY-JEN HWANG;Chen;Kuo, Hsu-Ko;Kuo, HK;CHING-YU CHEN;Hwang, J.-J.;Lin, L.-Y.;Yu, Y.-H.;Chang, C.-C.;Chang, K.-J.;Yen, C.-J.;Liu, H.-M.;Chen, C.-Y.;Kuo, H.-K.; Kuo, H.-K.; Chen, C.-Y.; Liu, H.-M.; Yen, C.-J.; Chang, K.-J.; Chang, C.-C.; Yu, Y.-H.; Lin, L.-Y.; Hwang, J.-J.; CHING-YU CHEN; Kuo, HK; Kuo, Hsu-Ko; Chen; JUEY-JEN HWANG; Chen, Ching-Yu; Liu, Hon-Man; CY; CHUNG-JEN YEN; Liu, HM; LIAN-YU LIN; Yen, Chung-Jen; Yen, CJ; Chang, King-Jen; HON-MAN LIU; Chang, KJ; Chang, Chien-Cheng; Chang, CC; Yu, Yau-Hua; Yu, YH; Lin, Lian-Yu; Hwang, Juey-Jen; Lin, LY; Hwang, JJ |
| 國家衛生研究院 |
2018-06 |
The interplay between oral microbiome, lifestyle factors, and genetic polymorphisms in the risk of oral squamous cell carcinoma
|
Hsiao, JR;Chang, CC;Lee, WT;Huang, CC;Ou, CY;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2018-05 |
A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers
|
Chang, KY;Chiang, NJ;Yen, CJ;Wu, SY;Chen, SH;Johnston, A;Bomalaski, JS;Wu, BW;Chen, LT |
| 國家衛生研究院 |
2018-04-05 |
ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G;Qin, S;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, G;Harris, WP;Chen, Z;Hubner, RA;Meyer, T;Sun, W;Harding, JJ;Hollywood, EM;Ma, J;Wan, PJ;Ly, M;Bomalaski, J;Johnston, A;Lin, CC;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2017-10-24 |
Investigating the association between diet and risk of head and neck cancer in Taiwan
|
Chang, CC;Lee, WT;Lee, YC;Huang, CC;Ou, CY;Lin, YH;Huang, JS;Wong, TY;Chen, KC;Hsiao, JR;Lu, YC;Tsai, ST;Lai, YH;Wu, YH;Hsueh, WT;Yen, CJ;Wu, SY;Chang, JY;Fang, SY;Wu, JL;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2017-08-29 |
Investigating the association between alcohol and risk of head and neck cancer in Taiwan
|
Huang, CC;Hsiao, JR;Lee, WT;Lee, YC;Ou, CY;Chang, CC;Lu, YC;Huang, JS;Wong, TY;Chen, KC;Tsai, ST;Fang, SY;Wu, JL;Wu, YH;Hsueh, WT;Yen, CJ;Wu, SY;Chang, JY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2017-06-15 |
Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stress
|
Wu, CY;Hsu, WL;Tsai, MH;Liang, JL;Lu, JH;Yen, CJ;Yu, HS;Noda, M;Lu, CY;Chen, CH;Yan, SJ;Yoshioka, T |
| 國家衛生研究院 |
2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy
|
Chiang, NJ;Shiah, HS;Lin, CC;Yen, CJ;Tsai, HJ;Wu, SY;Su, WC;Chang, KY;Chen, LT |
| 國家衛生研究院 |
2017-04-21 |
Regular recreational physical activity and risk of head and neck cancer
|
Lin, CL;Lee, WT;Ou, CY;Hsiao, JR;Huang, CC;Huang, JS;Wong, TY;Chen, KC;Tsai, ST;Fang, SY;Huang, TT;Wu, JL;Wu, YH;Hsueh, WT;Yen, CJ;Lai, YH;Liao, HC;Wu, SY;Yang, MW;Lin, FC;Chang, JY;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2017-01 |
Inhibition of the EGFR/STAT3/CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder
|
Wang, WJ;Li, CF;Chu, YY;Wang, YH;Hour, TC;Yen, CJ;Chang, WC;Wang, JM |
| 國家衛生研究院 |
2016-12 |
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
|
Chan, TS;Hsu, CC;Pai, VC;Liao, WY;Huang, SS;Tan, KT;Yen, CJ;Hsu, SC;Chen, WY;Shan, YS;Li, CR;Lee, MT;Jiang, KY;Chu, JM;Lien, GS;Weaver, VM;Tsai, KK |
| 國家衛生研究院 |
2016-11 |
Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
|
Chen, HA;Kuo, TC;Tseng, CF;Ma, JT;Yang, ST;Yen, CJ;Yang, CY;Sung, SY;Su, JL |
| 國家衛生研究院 |
2016-10-25 |
A comprehensive analysis on the association between tobacco-free Betel Quid and risk of Head and Neck Cancer in Taiwanese men
|
Wu, YH;Yen, CJ;Hsiao, JR;Ou, CY;Huang, JS;Wong, TY;Tsai, ST;Huang, CC;Lee, WT;Chen, KC;Fang, SY;Wu, JL;Hsueh, WT;Lin, FC;Yang, MW;Chang, JY;Liao, HC;Wu, SY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2016-09 |
Allergy symptoms, serum total immunoglobulin E, and risk of head and neck cancer
|
Liao, HC;Wu, SY;Ou, CY;Hsiao, JR;Huang, JS;Tsai, ST;Huang, CC;Wong, TY;Lee, WT;Chen, KC;Fang, SY;Wu, JL;Huang, TT;Wu, YH;Hsueh, WT;Yen, CJ;Yang, MW;Lin, FC;Lai, YH;Chang, JY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2016-05 |
Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma
|
Tsai, HW;Lin, YJ;Wu, HC;Chang, TT;Wu, IC;Cheng, PN;Yen, CJ;Chan, SH;Huang, W;Su, IJ |
| 國家衛生研究院 |
2016-05 |
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-11 |
HMBD and 5-AzadC combination reverses tumor suppressor CCAAT/enhancer binding protein delta to strengthen the death of liver cancer cells
|
Wang, JM;Li, CF;Tsai, HH;Ko, CY;Pan, YC;Yen, CJ;Lai, HY;Yuh, CH;Wu, WC |
| 國家衛生研究院 |
2015-07 |
Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis
|
Hsieh, YH;Chang, YY;Su, IJ;Yen, CJ;Liu, YR;Liu, RJ;Hsieh, WC;Tsai, HW;Wang, LHC;Huang, WY |
| 國家衛生研究院 |
2015-07 |
Alcohol drinking obliterates the inverse association between serum retinol and risk of head and neck cancer
|
Chen, KC;Hsueh, WT;Ou, CY;Huang, CC;Lee, WT;Fang, SY;Tsai, ST;Huang, JS;Wong, TY;Wu, JL;Yen, CJ;Wu, YH;Lin, FC;Yang, MW;Chang, JY;Liao, HC;Wu, SY;Hsiao, JR;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-03 |
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer
|
Lee, WT;Huang, CC;Chen, KC;Wong, TY;Ou, CY;Tsai, ST;Yen, CJ;Fang, SY;Lo, HI;Wu, YH;Hsueh, WT;Yang, MW;Lin, FC;Hsiao, JR;Huang, JS;Chang, JY;Chang, KY;Wu, SY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國家衛生研究院 |
2014-11 |
The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer
|
Tsai, ST;Wong, TY;Ou, CY;Fang, SY;Chen, KC;Hsiao, JR;Huang, CC;Lee, WT;Lo, HI;Huang, JS;Wu, JL;Yen, CJ;Hsueh, WT;Wu, YH;Yang, MW;Lin, FC;Chang, JY;Chang, KY;Wu, SY;Liao, HC;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國立成功大學 |
2014-11 |
Results of a phase I, open-label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary antitumour activity of AZD9150 in patients with advanced/metastatic hepatocellular carcinoma
|
Kang, Y. K.; Ryoo, BY; Kim, TY; Lee, KH; Lim, HY; Lee, SJ; Ikeda, M; Okusaka, T; Nadano, S; Lin, CC; Poon, TP; Yen, CJ; McCoon, P; Neumann, F; Vishwantahan, K; DuPont; Lyne, P |
| 國家衛生研究院 |
2014-10-24 |
Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5year follow-up
|
Wu, SY;Wu, YH;Yang, MW;Hsueh, WT;Hsiao, JR;Tsai, ST;Chang, KY;Chang, J;Yen, CJ |
| 國家衛生研究院 |
2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL |
| 中國醫藥大學 |
2014-06 |
Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma
|
(Wu CS);(Lee TY);鄒瑞煌(Ruey-Hwang Chou);(Yen CJ);黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)* |
| 國家衛生研究院 |
2014-05-05 |
Tea consumption and risk of head and neck cancer
|
Huang, CC;Lee, WT;Tsai, ST;Ou, CY;Lo, HI;Wong, TY;Fang, SY;Chen, KC;Huang, JS;Wu, JL;Yen, CJ;Hsueh, WT;Wu, YH;Yang, MW;Lin, FC;Chang, JY;Chang, KY;Wu, SY;Hsiao, JR;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 亞洲大學 |
2014-04 |
Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
|
Wu, CS;Wu, CS;Yen, CJ;Yen, CJ;鄒瑞煌;Chou, Ruey-Hwang;Chen, JN;Chen, JN;Huang, WC;Huang, WC;Wu, CY;Wu, CY;余永倫 |
| 中國醫藥大學 |
2014-04 |
Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2–induced Globo H expression
|
吳承修;(Yen CJ);鄒瑞煌(Ruey-Hwang Chou);陳佳妮;黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)* |
| 國家衛生研究院 |
2013-10 |
Investigating the association between oral hygiene and head and neck cancer
|
Chang, JS;Lo, HI;Wong, TY;Huang, CC;Lee, WT;Tsai, ST;Chen, KC;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, KY;Chang, JY;Ou, CY;Wang, YH;Weng, YL;Yang, HC;Wang, FT;Lin, CL;Huang, JS;Hsiao, JR |
| 國家衛生研究院 |
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-06 |
SUMOylated CPAP is required for IKK-mediated NF-kappaB activation and enhances HBx-induced NF-kappaB signaling in HCC
|
Yang, ST;Yen, CJ;Lai, CH;Lin, YJ;Chang, KC;Lee, JC;Liu, YW;Chang-Liao, PY;Hsu, LS;Chang, WC;Hung, WC;Tang, TK;Liu, YW;Hung, LY |
| 國家衛生研究院 |
2013-06 |
Oral hygiene and risk of head and neck cancer
|
Chang, J;Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Wang, YH;Weng, YL;Yang, HC;Lin, CL;Wang, FT |
| 國家衛生研究院 |
2013-04 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-02-01 |
Allergies and risk of head and neck cancer: An original study plus meta-analysis
|
Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Lin, CL;Wang, FT;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國家衛生研究院 |
2013-02 |
Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients
|
Hsieh, YH;Su, IJ;Yen, CJ;Tsai, TF;Tsai, HW;Tsai, HN;Huang, YJ;Chen, YY;Ai, YL;Kao, LY;Hsieh, WC;Wu, HC;Huang, W |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY |
| 國家衛生研究院 |
2012-07-27 |
Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma
|
Yen, CJ;Lin, YJ;Yen, CS;Tsai, HW;Tsai, TF;Chang, KY;Huang, WC;Lin, PW;Chiang, CW;Chang, TT |
| 國家衛生研究院 |
2011-11-15 |
Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
|
Chang, KY;Tsai, SY;Wu, CM;Yen, CJ;Chuang, BF;Chang, JY |
| 國家衛生研究院 |
2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou
|
Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY |
| 國家衛生研究院 |
2011-09 |
Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers
|
Yeh, K;Shen, YC;Li, CP;Yen, CJ;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Cheng, AL |
| 國家衛生研究院 |
2011-07-01 |
A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery
|
Tsai, HW;Lin, YJ;Lin, PW;Wu, HC;Hsu, KH;Yen, CJ;Chan, SH;Huang, W;Su, IJ |
| 國家衛生研究院 |
2011-06-23 |
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
|
Chen, YJ;Huang, WC;Wei, YL;Hsu, SC;Yuan, P;Lin, HY;Wistuba, I;Lee, JJ;Yen, CJ;Su, WC;Chang, KY;Chang, WC;Chou, TC;Chou, CK;Tsai, CH;Hung, MC |
| 國家衛生研究院 |
2010-10 |
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Li, CP;Chen, JS;Chen, LT;Yen, CJ;Lee, KD;Su, WP;Lin, PC;Lu, CH;Tsai, HJ;Chao, Y |
Showing items 36-85 of 99 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
